Product image of Insuman Rapid (Insulin Human) supplied by GNH India

Insuman Rapid

Active Ingredient:
Insulin Human
Origin:
EU

Insuman Rapid (Insulin Human)

Insulin Human, the active ingredient in Insuman Rapid, is an insulin presented as a solution for injection for subcutaneous use. It is used to control blood glucose in patients with type 1 and type 2 diabetes mellitus. By mimicking natural insulin, it helps regulate glucose metabolism.

GNH India supplies Insuman Rapid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable cold‑chain logistics for injectable products across multiple continents.

Manufacturer / TM Owner

Sanofi-Aventis Deutschland Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Insuman Rapid, a rapid‑acting insulin, is used to manage hyperglycemia in diabetes.

  • Type 1 diabetes mellitus: provides rapid glucose lowering to cover meals and correct hyperglycemia.
  • Type 2 diabetes mellitus: assists in post‑prandial glucose control when oral agents are insufficient.
  • Hospitalized patients with diabetes: enables precise insulin dosing for acute glycemic management.

How It Works

  • Insulin Human binds to insulin receptors on muscle, adipose and hepatic cells, activating the receptor’s tyrosine kinase activity. This triggers intracellular signaling cascades that promote glucose uptake, glycogen synthesis, and lipogenesis while suppressing hepatic gluconeogenesis, thereby lowering circulating blood glucose levels.

Side Effects

Insuman Rapid may cause a range of adverse reactions.

Common Side Effects

  • Hypoglycemia: low blood sugar episodes, especially if meals are missed.
  • Injection site reactions: redness, swelling, or itching at the injection site.
  • Weight gain: modest increase due to improved glucose utilization.
  • Lipodystrophy: localized fat tissue changes with repeated injections.
  • Edema: mild fluid retention.
  • Headache: transient discomfort.

Serious or Rare Side Effects

  • Severe hypoglycemia: neurological impairment requiring immediate treatment.
  • Anaphylactic reaction: life‑threatening allergy to insulin or excipients.
  • Insulin allergy: systemic rash, urticaria, or angioedema.
  • Hypokalemia: low potassium levels during rapid glucose shifts.
  • Acute allergic edema: rapid swelling of tissues.
  • Serum insulin antibodies: may alter insulin action.

Precautions & Warnings

When using Insuman Rapid, consider the following precautions.

  • Blood glucose monitoring: check levels frequently to avoid hypoglycemia.
  • Dose adjustments during illness: reduce or increase insulin based on carbohydrate intake and stress.
  • Renal impairment: use cautiously as reduced clearance may increase hypoglycemia risk.
  • Hypoglycemia unawareness: patients with impaired warning signs need close supervision.
  • Pregnancy and lactation: evaluate risk‑benefit ratio; insulin is generally preferred but consult a specialist.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake the vial.

Avoid Interactions

Insuman Rapid can interact with several medications.

Major Interactions (Avoid)

  • Beta‑blockers: may mask hypoglycemia symptoms, requiring careful monitoring.
  • Alcohol: can potentiate insulin’s glucose‑lowering effect, increasing hypoglycemia risk.

Moderate Interactions (Monitor Closely)

  • Thiazide diuretics: may raise blood glucose, necessitating dose adjustments.
  • Corticosteroids: can increase insulin resistance, requiring higher insulin doses.
  • Oral contraceptives: may affect insulin sensitivity, warranting closer glucose monitoring.
  • ACE inhibitors: may enhance insulin’s effect on potassium levels, monitor electrolytes.

Frequently Asked Questions

Insuman Rapid is a rapid‑acting insulin formulation used to lower blood glucose levels in adults with type 1 or type 2 diabetes mellitus, particularly to control post‑meal spikes and provide flexibility in insulin therapy.

Insulin Human mimics the action of natural human insulin by binding to insulin receptors on muscle, fat, and liver cells. This activates signaling pathways that increase glucose uptake, promote glycogen storage, and suppress hepatic glucose production, thereby reducing blood sugar concentrations.

The dose of Insuman Rapid is individualized. A qualified prescriber determines the amount, timing, and frequency based on the patient’s blood glucose patterns, carbohydrate intake, and overall treatment plan.

Insulin is generally considered the preferred glucose‑lowering agent during pregnancy and lactation because it does not cross the placenta in harmful amounts. However, the prescriber should evaluate the risk‑benefit profile for each patient.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, cold‑chain shipping details, and necessary import documentation.

Insuman Rapid contains human insulin, whereas many newer rapid‑acting analogues use modified insulin molecules for faster onset. Both classes lower post‑prandial glucose, but analogues may have slightly different pharmacokinetic profiles. Choice depends on clinical response, cost, and prescriber preference.

Insuman Rapid should be stored at 2‑8 °C (refrigerated) in its original packaging, protected from light. Do not freeze or shake the vial. Once in use, it may be kept at controlled room temperature for a limited period as indicated on the label.

Insuman Rapid is given by subcutaneous injection, typically into the abdomen, thigh, or upper arm. The injection should be performed using a sterile needle, and the site should be rotated to reduce the risk of lipodystrophy.

The most serious risks include severe hypoglycemia, which can cause loss of consciousness or seizures, and allergic reactions ranging from rash to anaphylaxis. Prompt recognition and medical attention are essential if these events occur.

Insuman Rapid is contraindicated in patients with known hypersensitivity to insulin human or any excipients in the formulation. It should also be used with caution in individuals with recurrent severe hypoglycemia or those who are unable to recognize hypoglycemia symptoms.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Insulin Human

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT